Chakrabarti Advanced Technology (CAT) is a privately funded R&D Institute that conducts basic scientific research on areas of high global impact. Founded by Dr. Raj Chakrabarti (AB, Harvard; PhD, Princeton; formerly Professor of Chemical Engineering at Carnegie Mellon University and Purdue University), its focus areas include:
Our research has led to the development of cutting-edge technology platforms for drug discovery and development as well as for the development of associated companion diagnostic tests.

In addition to conducting internal research, it also collaborates with leading academic institutions and research centers on high impact external projects. Selected collaborators include:
  • Vanderbilt University: Discovery and Optimization of Novel cGAS Inhibitors
  • The Italian Cystic Fibrosis Foundation/University of Palermo: Targeting Nonsense Mutations via Optimization of TRIDs
  • The Wistar Institute and Thomas Jefferson University: Discovery and Optimization of Protein Degraders
  • Yale University: Optimization of TLR9 Inhibitors